Mural Oncology
MURA
MURA was delisted on the 4th of December, 2025.
74 hedge funds and large institutions have $29.8M invested in Mural Oncology in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 28 reducing their positions, and 20 closing their positions.
8.53% less ownership
Funds ownership: 64.41% → 55.88% (-8.5%)
13% less capital invested
Capital invested by funds: $34.2M → $29.8M (-$4.42M)
14% less funds holding
Funds holding: 86 → 74 (-12)
50% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 28
60% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$354K |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
+$310K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$205K |
| 4 |
Two Sigma Investments
New York
|
+$130K |
| 5 |
Millennium Management
New York
|
+$106K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
-$2.33M |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
-$556K |
| 3 |
Goldman Sachs
New York
|
-$421K |
| 4 |
Primecap Management
Pasadena,
California
|
-$311K |
| 5 |
AGM
Alpine Global Management
New York
|
-$294K |
MURA Hedge Fund Activity: Q3 2024 in Review
74 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q3 2024, worth a combined $29.8M — down 13% from $34.2M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of MURA and 8 opened new positions — a net loss of 12 holders — while 28 trimmed existing stakes and 14 added.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $354K. The largest seller was Westfield Capital Management, exiting entirely with an estimated $2.33M sold.
- 74 institutional investors held Mural Oncology (MURA) as of Q3 2024, down from 86 in Q2 2024.
- Funds reported $29.8M of Mural Oncology stock for Q3 2024, down 13% quarter-over-quarter.
- 8 funds opened new Mural Oncology positions in Q3 2024 and 20 closed out, a net change of -12 holders.
- The largest Mural Oncology buyer in Q3 2024 was Point72 Asset Management, an estimated $354K added.
- The largest Mural Oncology seller in Q3 2024 was Westfield Capital Management, an estimated $2.33M sold.
Based on aggregated 13F filings for Q3 2024.